Search

everythinglearnresearchcommunity

for

Search:↓

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

Microneedling is a promising, simple, and cost-effective treatment for hair loss that works well with other therapies.

Platelet-Rich Fibrin (PRF) can speed up healing in chronic wounds, improve hair density, and act as a natural filler for skin rejuvenation, but its use in hair loss treatment needs more evaluation.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

The document discusses hair and nail conditions, updates on treatments for alopecia, and controversies around finasteride use.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.

Many hair loss myths lack strong evidence, but some treatments are proven to work.

Some moles can disappear naturally, maintenance therapy for Stage 1 mycosis fungoides may not be necessary, allergic skin reactions in children are rising, weekly methotrexate for psoriasis is more effective than daily, long-term finasteride use improves hair growth with few side effects, and petrolatum improves UV therapy for psoriasis.

Some CAM therapies help with pediatric atopic dermatitis, but more research is needed.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

A test for nail fungus was most accurate with PAS stain, low-dose spironolactone helped two-thirds of acne patients, metformin reduced symptoms of HIV-related fat distribution changes with some side effects, and skin examination with dermoscopy was better at detecting abnormal moles, while temporary tattoos can cause skin reactions.

Betamethasone injections are more effective than Clobetasol for treating alopecia areata in children.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

PRP combined with Ayurvedic medicine may effectively treat hair loss.

Low zinc and copper levels may indicate Telogen Effluvium.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Combining corticosteroids and non-ablative fractional laser therapy may effectively treat extensive alopecia areata.

We need better research to improve alopecia treatment and patient care.

More research is needed to confirm the long-term effects of oral drugs for chronic central serous chorioretinopathy.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Electric current quickly reduces hand sweating but the effect doesn't last long.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Topical Saw Palmetto and Trichogen Veg Complex increased hair count by 11.9% and improved hair growth in 48% of men with hair loss.

Finasteride for hair loss doesn't harm erectile function; weight loss and exercise improve it.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

PRP therapy can be effective for early-stage common hair loss, with most patients seeing improvement, but there are inconsistencies in treatment methods.